Programs, populations, and payments verified via SAMHSA.
- Level of care
- Detox · Inpatient · IOP · MAT
- Service settings
- Hospital inpatient/24-hour hospital inpatient, Outpatient, Residential/24-hour residential, Hospital inpatient detoxification, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Residential detoxification, Short-term residential
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model, Relapse prevention, Substance use disorder counseling
- Age groups
- Children/Adolescents
- Special populations
- Adolescents, Young adults, Adult women, Pregnant/postpartum women, Adult men, Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Clonidine, Medication for mental disorders, Nicotine replacement
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services, Mentoring/peer support, Employment counseling or training
- Facility operation
- Private non-profit organization